Hemoptysis associated with Klebsiella pneumoniae respiratory infection and severe thoracic aortic aneurysm
Main Article Content
Abstract
Hemoptysis has a broad differential diagnosis, including infectious, neoplastic, chronic bronchopulmonary, and vascular causes. In smokers with probable chronic obstructive pulmonary disease, blood-streaked sputum may initially suggest a respiratory infection; however, concomitant thoracic vascular disease requires a comprehensive diagnostic approach. Case presentation a 64-year-old male smoker was admitted with dyspnea and hemoptysis. Symptoms began one month before admission with paroxysmal nocturnal dyspnea, exertional dyspnea, and lower limb edema, followed by approximately 5 kg weight loss, productive yellowish cough with blood-streaked sputum, and progression of dyspnea to minimal exertion. On admission, he was alert, afebrile, hemodynamically stable, and required supplemental oxygen. Laboratory tests showed leukocytosis with neutrophilia, and empirical antimicrobial therapy was started. Sputum culture isolated Klebsiella pneumoniae, susceptible to levofloxacin, amikacin, meropenem, and trimethoprim/sulfamethoxazole; GeneXpert was negative. Contrast-enhanced computed tomography revealed severe thoracic aortic aneurysmal dilatation measuring 62 mm, immediately distal to the origin of the left subclavian artery, without signs of acute aortic syndrome. The patient received targeted antimicrobial therapy, bronchodilators, oxygen therapy, and cardiovascular management. This case emphasizes that hemoptysis should not be attributed solely to infection after the first positive finding. Contrast-enhanced computed tomography identified a high-risk vascular condition that changed follow-up and therapeutic planning.
Downloads
Article Details

This work is licensed under a Creative Commons Attribution 4.0 International License.
References
1. Corey R. Hemoptysis. En: Walker HK, Hall WD, Hurst JW, editores. Clinical Methods: The History, Physical, and Laboratory Examinations. 3a ed. Boston: Butterworths; 1990. Disponible en: https://www.ncbi.nlm.nih.gov/books/NBK360 /
2. Olsen KM, Manouchehr-Pour S, Donnelly EF, Henry TS, Berry MF, Boiselle PM, et al. ACR Appropriateness Criteria® Hemoptysis. J Am Coll Radiol. 2020;17(5S):S148-S159. doi:10.1016/j.jacr.2020.01.043. Disponible en: https://pubmed.ncbi.nlm.nih.gov/32370959/
3. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for prevention, diagnosis and management of COPD: 2025 report. Fontana (WI): Global Initiative for Chronic Obstructive Lung Disease; 2025. Disponible en: https://goldcopd.org
4. Isselbacher EM, Preventza O, Black JH, Augoustides JG, Beck AW, Bolen MA, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation. 2022;146(24):e334-e482. doi:10.1161/CIR.0000000000001106. Disponible en: https://www.ahajournals.org/doi/10.1161/CIR.0000000000001106
5. Martin RM, Bachman MA. Colonization, infection, and the accessory genome of Klebsiella pneumoniae. Front Cell Infect Microbiol. 2018;8:4. doi:10.3389/fcimb.2018.00004.
6. Chen J, Li J, Huang F, Huang J, Zhang G, Huang Y, et al. Clinical characteristics, risk factors and outcomes of Klebsiella pneumoniae pneumonia developing secondary Klebsiella pneumoniae bloodstream infection. BMC Pulm Med. 2023;23:102. doi:10.1186/s12890-023-02394-8. Disponible en: https://link.springer.com/article/10.1186/s12890-023-02394-8
7. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D, et al. The CARE guidelines: consensus-based clinical case reporting guideline development. J Med Case Rep. 2013;7:223. doi:10.1186/1752-1947-7-223. Disponible en: https://jmedicalcasereports.biomedcentral.com/articles/10.1186/1752-1947-7-223